Advertisement
Screener

PULMONX CORPORATION (LUNG) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

Pulmonx Corp Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Pulmonx Corp return tang equity for the quarter ending 2026-06-30 was -130.53%, a change of -45.23% year-over-year.
  • Pulmonx Corp return tang equity for the quarter ending 2026-03-31 was -122.52%, a change of -46.74% year-over-year.
  • Pulmonx Corp return tang equity for the quarter ending 2025-12-31 was -104.29%, a change of -36.73% year-over-year.
  • Pulmonx Corp return tang equity for the quarter ending 2025-09-30 was -98.36%, a change of -36.01% year-over-year.
  • Pulmonx Corp return tang equity for fiscal 2025 was -104.29%, a change of -36.73% from fiscal 2024.
  • Pulmonx Corp return tang equity for fiscal 2024 was -67.56%, a change of -15.08% from fiscal 2023.
  • Pulmonx Corp return tang equity for fiscal 2023 was -52.47%, a change of -13.59% from fiscal 2022.
  • Pulmonx Corp return tang equity for fiscal 2022 was -38.89%, a change of -13.36% from fiscal 2021.
Available history
2018-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30-130.53%-$48.12M$36.86M
2026-03-31-122.52%-$53.21M$43.43M
2025-12-31-104.29%-$54M$51.78M
2025-09-30-98.36%-$56.75M$57.7M
2025-06-30-85.29%-$56.94M$66.76M
2025-03-31-75.79%-$57.09M$75.33M
2024-12-31-67.56%-$56.39M$83.48M
2024-09-30-62.35%-$57.11M$91.59M
2024-06-30-58.54%-$57.86M$98.85M
2024-03-31-54.30%-$58.73M$108.17M
2023-12-31-52.47%-$60.84M$115.95M
2023-09-30-49.65%-$61.24M$123.35M
2023-06-30-46.01%-$60.51M$131.53M
2023-03-31-41.67%-$58.96M$141.48M
2022-12-31-38.89%-$58.92M$151.52M
2022-09-30-35.81%-$57.65M$160.96M
2022-06-30-31.63%-$53.66M$169.63M
2022-03-31-28.95%-$51.98M$179.57M
2021-12-31-25.53%-$48.66M$190.63M
2021-09-30-22.46%-$44.95M$200.19M
2021-06-30-18.74%-$38.63M$206.2M
2021-03-31-17.61%-$37.58M$213.45M
2020-12-31-14.43%-$32.23M$223.4M
2020-09-3013.17%-$27.6M-$209.65M
2020-06-3013.46%-$28.08M-$208.62M
2020-03-3111.04%-$21.74M-$196.9M
2019-12-3110.88%-$20.7M-$190.24M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-31-104.29%-$54M$51.78M
2024-12-31-67.56%-$56.39M$83.48M
2023-12-31-52.47%-$60.84M$115.95M
2022-12-31-38.89%-$58.92M$151.52M
2021-12-31-25.53%-$48.66M$190.63M
2020-12-31-14.43%-$32.23M$223.4M
2019-12-3110.88%-$20.7M-$190.24M
2018-12-3111.04%-$18.48M-$167.33M

Similar stocks

Stock NameCountryMarket CapPE Ratio
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Microbot Medical Inc. (MBOT)$0.089B-7.97
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B